Position in ANNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,871,013
+$990,799 QoQ
Shares Held
698,739
+21.8% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 98.41171023801448.ToString("F0")%
Shared 0.ToString("F0")%
None 1.5882897619855194.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ANNX ranks #40 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,871,013 | 698,739 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,880,214 | 573,748 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,248,904 | 409,477 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $904,736 | 376,974 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $671,430 | 347,892 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,209,422 | 235,755 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,291,826 | 218,214 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $738,018 | 150,616 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $207,248 | 28,905 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $74,600 | 16,432 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $26,474 | 11,218 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,181 | 17,381 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,066 | 277 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,406 | 272 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,643 | 266 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $652 | 173 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,750 | 2,839 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $161,112 | 14,022 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,065 | 111 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,498 | 111 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $109,216 | 3,923 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $293,526 | 11,727 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $334,464 | 11,064 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||